Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Wells, S. Strickland (1997)
Regulated localization confers multiple functions on the protease urokinase plasminogen activatorJournal of Cellular Physiology, 171
T. Seki, H. Imai, S. Uno, T. Ariga, T. Gelehrter (1996)
Production of Tissue-Type Plasminogen Activator (t-PA) and Type-1 Plasminogen Activator Inhibitor (PAI-1) in Mildly Cirrhotic Rat LiverThrombosis and Haemostasis, 75
N. Marx, T. Bourcier, G. Sukhova, P. Libby, J. Plutzky (1999)
PPARγ Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 Expression PPARγ as a Potential Mediator in Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 19
D. Loskutoff, S. Curriden, Geng Hu, G. Deng (1999)
Regulation of cell adhesion by PAI‐1APMIS, 107
T. Nordt, D. Schneider, B. Sobel (1994)
Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.Circulation, 89 1
R. Bergman, M. Ader (2000)
Free Fatty Acids and Pathogenesis of Type 2 Diabetes MellitusTrends in Endocrinology & Metabolism, 11
P. Andreasen, B. Georg, L. Lund, A. Riccio, S. Stacey (1990)
Plasminogen activator inhibitors: hormonally regulated serpinsMolecular and Cellular Endocrinology, 68
R. Brun, B. Spiegelman (1997)
PPAR gamma and the molecular control of adipogenesis.The Journal of endocrinology, 155 2
D. Loskutoff (1991)
Regulation of PAI-1 gene expressionFibrinolysis and Proteolysis, 5
The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Synthesis and Secretion of Plasminogen Activator
J. Heaton, S. Kathju, T. Gelehrter (1992)
Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides.Molecular endocrinology, 6 1
K. Danø, J. Rømer, B. Nielsen, S. Bjørn, C. Pyke, J. Rygaard, L. Lund (1999)
Cancer invasion and tissue remodeling‐cooperation of protease systems and cell typesAPMIS, 107
M. Alessi, D. Bastelica, P. Morange, B. Berthet, I. Leduc, M. Verdier, O. Geel, I. Juhan-Vague (2000)
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.Diabetes, 49 8
T. Seki, T. Gelehrter (1996)
Interleukin‐1 induction of type‐1 plasminogen activator inhibitor (PAI‐1) gene expression in the mouse hepatocyte line, AML 12Journal of Cellular Physiology, 168
P. Feng, M. Ohlsson, T. Ny (1990)
The structure of the TATA-less rat tissue-type plasminogen activator gene. Species-specific sequence divergences in the promoter predict differences in regulation of gene expression.The Journal of biological chemistry, 265 4
S. Chernick, P. Spooner, M. Garrison, R. Scow (1986)
Effect of epinephrine and other lipolytic agents on intracellular lipolysis and lipoprotein lipase activity in 3T3-L1 adipocytes.Journal of lipid research, 27 3
P. Morange, R. Lijnen, M. Alessi, F. Koop, D. Collen, I. Juhan-vague (2000)
Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.Arteriosclerosis, thrombosis, and vascular biology, 20 4
B. Desvergne, W. Wahli (1999)
Peroxisome proliferator-activated receptors: nuclear control of metabolism.Endocrine reviews, 20 5
The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Autocrine Regulation of Human Preadipocyte Migration by Plasminogen Activator Inhibitor-1
B. Janand-Delenne, C. Chagnaud, D. Raccah, M. Alessi, I. Juhan-vague, P. Vague (1998)
Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in womenInternational Journal of Obesity, 22
K. Schoonjans, B. Staels, J. Auwerx (1996)
The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.Biochimica et biophysica acta, 1302 2
J. Vassalli, A. Sappino, D. Belin (1991)
The plasminogen activator/plasmin system.The Journal of clinical investigation, 88 4
M. Cigolini, G. Targher, I. Andreis, M. Tonoli, G. Agostino, G. Sandre (1996)
Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men.Arteriosclerosis, thrombosis, and vascular biology, 16 3
U. Reuning, Magdolen, O. Wilhelm, Kerstin Fischer, Lutz, Henner Graeff, Manfred Schmitt (1998)
Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review).International journal of oncology, 13 5
A. Gils, P. Declerck (1998)
Structure-function Relationships in Serpins: Current Concepts and ControversiesThrombosis and Haemostasis, 80
J. Heaton, T. Gelehrter (1990)
Cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor messenger RNAs in rat hepatoma cells.Molecular endocrinology, 4 1
K. Maeda, K. Okubo, I. Shimomura, Katsuya Mizuno, Y. Matsuzawa, K. Matsubara (1997)
Analysis of an expression profile of genes in the human adipose tissue.Gene, 190 2
C. Hekman, D. Loskutoff (1985)
Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.The Journal of biological chemistry, 260 21
I. Juhan-vague, M. Alessi (1996)
Fibrinolysis and risk of coronary artery diseaseFibrinolysis and Proteolysis, 10
C. Heussen, E. Dowdle (1980)
Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.Analytical biochemistry, 102 1
David Waltz, Lisa Natkin, Ross Fujita, Ying‐Ying Wei, H. Chapman (1997)
Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.The Journal of clinical investigation, 100 1
S. Stefansson, D. Lawrence (1996)
The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin.Nature, 383 6599
F. Samad, Koji Yamamoto, D. Loskutoff (1996)
Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.The Journal of clinical investigation, 97 1
E. Planus, G. Barlovatz-Meimon, R. Rogers, S. Bonavaud, D. Ingber, Ning Wang (1997)
Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading.Journal of cell science, 110 ( Pt 9)
E. Levin (1986)
Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells.Blood, 67 5
A. Chang, A. Kuo, E. Barnathan, S. Okada (1998)
Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase.Arteriosclerosis, thrombosis, and vascular biology, 18 12
T. Seki, T. Ariga, K. Saitoh, T. Sugawara, S. Oshiba (1990)
Hormonal regulation of plasminogen activator production by rat hepatocytes in primary culture.Thrombosis research, 58 6
T. Nordt, H. Sawa, Satoshi Fujii, B. Sobel (1995)
Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo.Circulation, 91 3
P. Chomczyński, N. Sacchi (1987)
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.Analytical biochemistry, 162 1
S. Jolly, Y. Lombardo, J. Lech, L. Menahan (1980)
Effect of aging and cellularity on lipolysis in isolated mouse fat cells.Journal of lipid research, 21 1
N. Marx, T. Bourcier, G. Sukhova, P. Libby, J. Plutzky (1999)
PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease.Arteriosclerosis, thrombosis, and vascular biology, 19 3
L. Wise, H. Green (1979)
Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells.The Journal of biological chemistry, 254 2
S. Uno, M. Nakamura, Y. Ohomagari, S. Matsuyama, T. Seki, T. Ariga (1998)
Regulation of tissue-type plasminogen activator (tPA) and type-1 plasminogen activator inhibitor (PAI-1) gene expression in rat hepatocytes in primary culture.Journal of biochemistry, 123 5
P. Morange, J. Aubert, F. Peiretti, H. Lijnen, Philippe Vague, M. Verdier, R. Négrel, I. Juhan-Vague, M. Alessi (1999)
Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue.Diabetes, 48 4
J. Heaton, V. Nebes, L. Odell, S. Morris, T. Gelehrter (1989)
Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor gene expression in primary cultures of rat hepatocytes.Molecular endocrinology, 3 1
A. Gils, P. Declerck (1998)
Modulation of Plasminogen Activator Inhibitor 1 by Triton X-100 – Identification of Two Consecutive Conformational TransitionsThrombosis and Haemostasis, 80
Teake Kooistra, P Bosma, H. Tons, A. Berg, Peter Meyer, Hans Princen (1989)
Plasminogen Activator Inhibitor 1: Biosynthesis and mRNA Level Are Increased by Insulin in Cultured Human HepatocytesThrombosis and Haemostasis, 62
I. Shimomura, Tohru Funahasm, Masahiko Takahashi, K. Maeda, K. Kotani, Tadashi Nakamura, S. Yamashita, M. Miura, Y. Fukuda, K. Takemura, K. Tokunaga, Y. Matsuzawa (1996)
Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeistyNature Medicine, 2
A. Vidal-Puig, R. Considine, M. Jimenez-Linan, A. Werman, W. Pories, J. Caro, J. Flier (1997)
Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.The Journal of clinical investigation, 99 10
P. Declerck, M. Verstreken, P. Carmeliet, D. Collen (1994)
Generation of monoclonal antibodies against autologous proteins in gene-inactivated miceFibrinolysis and Proteolysis, 8
P. Declerck, M. Verstreken, D. Collen (1995)
Immunoassay of Murine t-PA, u-PA and PAI-1 Using Monoclonal Antibodies Raised in Gene-inactivated MiceThrombosis and Haemostasis, 74
Y. Liu, X. Peng, T. Ny (1991)
Tissue-specific and time-coordinated hormone regulation of plasminogen-activator-inhibitor type I and tissue-type plasminogen activator in the rat ovary during gonadotropin-induced ovulation.European journal of biochemistry, 195 2
S. Mohanam, Y. Go, R. Sawaya, B. Venkaiah, P. Mohan, G. Kouraklis, Z. Gokaslan, G. Lagos, J. Rao (1999)
Elevated levels of urokinase-type plasminogen activator and its receptor during tumor growth in vivo.International journal of oncology, 14 1
Adipose tissue expresses a variety of genes including tumor necrosis factor α and type‐1 plasminogen activator inhibitor (PAI‐1); and these factors, produced by adipocytes, may be associated with the risk of coronary events in obesity. In this study, we characterized the production of fibrinolytic factors including tissue‐type plasminogen activator (tPA), urokinase‐type PA (uPA), and PAI‐1 in the differentiation of preadipocytes, and examined the hormonal regulation of these fibrinolytic factors in mature adipocytes. Mouse 3T3‐L1 preadipocytes were employed as a model of adipocytes. Adipocyte differentiation was induced by insulin, dexamethasone, and 3‐isobutyl‐1‐methyl xanthine (IBMX). α‐Glycerophosphate dehydrogenase (GPDH) activity and glucose transporter 4 (GLUT4) mRNA, indices for adipocyte maturation, were induced on Day 4, and gradually increased. GPDH activity reached its maximum level on Day 14. The level of tPA, a major PA in preadipocytes, dramatically decreased with differentiation. On the other hand, that of uPA reciprocally increased. PAI‐1 production was also dramatically induced concomitant with differentiation. In mature adipocytes, uPA production was dominant (25 μg/ml/24 h vs. 0.8 μg/ml/24 h for tPA). Total PA activity in the mature adipocytes was reduced by insulin or dexamethasone, but not by glucagon. Insulin, IBMX, and dexamethasone significantly decreased both uPA and tPA production, and increased PAI‐1 production. Glucagon had no effect on the production of these fibrinolytic factors. Our results reveal that uPA is one of the markers for the differentiation of 3T3‐L1 cells and that insulin, IBMX, and dexamethasone are potent regulators of the fibrinolytic activity in differentiated 3T3‐L1 cells, reciprocally affecting PA and PAI‐1 levels in them. © 2001 Wiley‐Liss, Inc.
Journal of Cellular Physiology – Wiley
Published: Oct 1, 2001
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.